Sunday 11 October 2026 Export all KDP data to Excel Powerpack

Keurig Dr Pepper, Inc

KDP Consumer Defensive Beverages Non Alcoholic

Keurig Dr Pepper, Inc’s revenue for fiscal 2025 (year ended December 2025) was $16.6 billion, up 8.16% from fiscal 2024. In the quarter to June 2026, revenue grew 75.6%, EPS fell 90.0%, free cash flow grew 120.4% and total debt rose 115.4%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; dividend growth for five consecutive years, revenue growth for five; insiders bought in the last twelve months.

31.76 0.50 +1.60%
Market cap
$42.5B
P/E
32.1×
Fwd P/E
15.0×
Dividend yield
2.90%
F-score
7/9
Altman Z
1.35
Beneish M
−2.32
Dividend safety
40/100

Keurig Dr Pepper, Inc (KDP) SEC filings, changes and red flags

Red flags

  • Officer departure

    Keurig Dr Pepper, Inc reported the departure of an officer or director

    8-K filed · The filing · sec.gov

  • Impairment

    Keurig Dr Pepper, Inc recorded a goodwill impairment of $306.0 million in fiscal 2024

    10-K filed · The filing · sec.gov

Filings

Form Period Filed What it reports Flags
8-K Oct 1, 2026 8.01 Other events; 9.01 Financial statements and exhibits
8-K Sep 28, 2026 8.01 Other events
8-K Sep 16, 2026 8.01 Other events; 9.01 Financial statements and exhibits
8-K Aug 28, 2026 8.01 Other events; 9.01 Financial statements and exhibits
8-K Aug 10, 2026 5.02 Departure or appointment of directors or officers Officer departure
10-Q Jun 30, 2026 P1I2: 47 added · 9 removed · 25 modified
P2I1A: no comparison — the earlier filing's Item cannot be compared
8-K Aug 6, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jun 22, 2026 5.02 Departure or appointment of directors or officers
8-K Jun 23, 2026 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits
8-K Jun 16, 2026 5.07 Submission of matters to a vote of security holders; 8.01 Other events
8-K/A Mar 30, 2026 9.01 Financial statements and exhibits
8-K May 21, 2026 8.01 Other events
8-K May 20, 2026 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Mar 31, 2026
8-K Apr 23, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Mar 30, 2026 1.01 Entry into a material definitive agreement; 1.02 Termination of a material definitive agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sales of equity securities; 5.03 Amendments to the articles or bylaws; change in fiscal year; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Mar 26, 2026 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits
8-K Mar 12, 2026 8.01 Other events
8-K Mar 6, 2026 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits
10-K Dec 31, 2025 1: 5 added · 6 removed · 24 modified
1A: 116 added · 6 removed · 40 modified
7: 15 added · 25 removed · 39 modified
8-K Feb 24, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Feb 23, 2026 1.01 Entry into a material definitive agreement; 3.02 Unregistered sales of equity securities; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits
8-K Feb 12, 2026 5.02 Departure or appointment of directors or officers; 8.01 Other events
8-K Feb 3, 2026 8.01 Other events; 9.01 Financial statements and exhibits
8-K Dec 18, 2025 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits
8-K Dec 9, 2025 8.01 Other events; 9.01 Financial statements and exhibits
8-K Nov 21, 2025 5.02 Departure or appointment of directors or officers
8-K Nov 21, 2025 8.01 Other events
8-K Oct 26, 2025 1.01 Entry into a material definitive agreement; 3.02 Unregistered sales of equity securities; 9.01 Financial statements and exhibits
10-Q Sep 30, 2025
8-K Oct 27, 2025 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Oct 27, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Aug 26, 2025 8.01 Other events
8-K Sep 16, 2025 8.01 Other events; 9.01 Financial statements and exhibits
8-K Aug 24, 2025 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Jun 30, 2025
10-K Dec 31, 2024 Impairment

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.